SEC Form 4 · accession 0001191434-16-000006
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne S. Springate
Officer — Sr VP of Operations
Period of report
Jun 21, 2016
Accepted (ET)
Jun 23, 2016 · 1:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Common Stock | $0.13 | Jun 21, 2016 | A | 150,000 | A | Jun 21, 2017 | Jun 21, 2026 | Common Stock | 150,000 | 150,000 | D |